
Arrowhead Pharmaceuticals, Inc.
USD83.14
+2.64 (+3.28%)
CEO
Christopher R. Anzalone
IPO Date
1993-12-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$82.00
Prev. Close
$80.50
Day Low
$78.86
Day High
$84.06
52W Low
$14.30
52W High
$84.55
Market Cap
$11.71B
Volume
1.29M
| 8 May 2026 |
| RBC Capital |
| Outperform |
| Outperform |
| maintain |
| 21 Apr 2026 | Morgan Stanley | Equal Weight | Overweight | upgrade |
| 25 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 10 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 22 Jan 2026 | B. Riley Securities | Buy | Buy | maintain |
| 21 Jan 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 13 Jan 2026 | Piper Sandler | Overweight | Overweight | maintain |